ETAEX
Price
$13.30
Change
+$0.15 (+1.14%)
Updated
Jun 26 closing price
Net Assets
96.07M
PRGTX
Price
$22.68
Change
+$0.18 (+0.80%)
Updated
Jun 26 closing price
Net Assets
4.77B
Interact to see
Advertisement

ETAEX vs PRGTX

Header iconETAEX vs PRGTX Comparison
Open Charts ETAEX vs PRGTXBanner chart's image
Eventide Exponential Technologies A
Price$13.30
Change+$0.15 (+1.14%)
VolumeN/A
Net Assets96.07M
T. Rowe Price Global Technology
Price$22.68
Change+$0.18 (+0.80%)
VolumeN/A
Net Assets4.77B
ETAEX vs PRGTX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETAEX vs. PRGTX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETAEX is a Hold and PRGTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 4.77B vs. ETAEX (96.1M). ETAEX (0.00) and PRGTX (0.00) have matching dividends . ETAEX was incepted earlier than PRGTX: ETAEX (5 years) vs PRGTX (25 years). ETAEX (1.74) is less costly to investors than PRGTX (0.92). ETAEX is a more actively managed with annual turnover of: 70.00 vs. PRGTX (31.40). ETAEX has a lower initial minimum investment than PRGTX: ETAEX (1000) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 13.75 vs. ETAEX (11.82).
ETAEXPRGTXETAEX / PRGTX
Total Expense Ratio1.680.92183%
Annual Report Gross Expense Ratio1.740.92189%
Fund Existence5 years25 years-
Gain YTD-0.9797.862-12%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets96.1M4.77B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.8213.7586%
Returns for 3 years12.3978.1516%
Returns for 5 yearsN/A12.05-
Returns for 10 yearsN/A70.45-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSQRX31.18N/A
N/A
Goldman Sachs Small Cap Value R
GKIRX26.54N/A
N/A
Goldman Sachs Income Builder Inv
AHSZX19.08N/A
N/A
Alger Health Sciences Z
BRULX16.00N/A
N/A
MFS Blended Research Value Equity R3
TRZLX42.84N/A
N/A
T. Rowe Price US Large-Cap Core Z